Drugs Approved for Ovarian Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for ovarian cancer. The list includes generic and brand names. This page also lists common drug combinations used in ovarian cancer. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in ovarian cancer that are not listed here.

Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Carboplatin
Clafen (Cyclophosphamide)
Cisplatin
Cyclophosphamide
Cytoxan (Cyclophosphamide)
Doxorubicin Hydrochloride
Dox-SL (Doxorubicin Hydrochloride Liposome)
DOXIL (Doxorubicin Hydrochloride Liposome)
Doxorubicin Hydrochloride Liposome
Evacet (Doxorubicin Hydrochloride Liposome)
Gemcitabine Hydrochloride
Gemzar (Gemcitabine Hydrochloride)
Hycamtin (Topotecan Hydrochloride)
LipoDox (Doxorubicin Hydrochloride Liposome)
Neosar (Cyclophosphamide)
Paclitaxel
Paraplat (Carboplatin)
Paraplatin (Carboplatin)
Platinol (Cisplatin)
Platinol-AQ (Cisplatin)
Taxol (Paclitaxel)
Topotecan Hydrochloride
 

Drug Combinations Used in Ovarian Cancer

BEP
CARBOPLATIN-TAXOL
GEMCITABINE-CISPLATIN
 

Back to Top